Biotech News

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

Neuronetics (STIM)Neuronetics2026-07-28 12:32 ESTCompany update

New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future care delivery MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines

Neuronetics

Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses...

Recent company news

STIMNeuronetics2026-08-03 12:00 EST

Stock data

Close: 2.25 USD
Market cap: 108.56M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

Related news

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems

AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect

Neuronetics

Recent company news

Neuronetics and Jorey Chernett Announce Shared Vision

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Stock data